Medical Biochemistry

Uzm. Dr. Mürvet Algemi

Doctor and researcher Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi İstanbul
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Biochemistrysaglik.gov.trFrom source
  • Department name at the sourceBiyokimya ve Klinik Biyokimyasaglik.gov.trFrom source
  • InstitutionKanuni Sultan Süleyman Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
  • Publications10 publicationsORCID, Europe PMC, OpenAlexFrom source
  • ORCID0000-0001-5117-528XORCIDFrom source
  • Last synchronised5 November 2026 08:56https://kanunieah.saglik.gov.tr/TR-1472837/doktorlarimiz.html#murvet-algemisaglik.gov.tr

Scientific work

Publications

10 publications
Publications by year Most: 5, in 2026
  1. 2017: 1 publication
  2. 2018: 0 publications
  3. 2019: 0 publications
  4. 2020: 0 publications
  5. 2021: 0 publications
  6. 2022: 0 publications
  7. 2023: 0 publications
  8. 2024: 1 publication
  9. 2025: 3 publications
  10. 2026: 5 publications

  1. Serum Neurofilament Light Chain in Diabetic Polyneuropathy: Associations with Neuropathy Burden, Balance Impairment, and Fear of Falling

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15187142 PMID 42795915 Open-access full textSource: ORCID

  2. Reduced Circulating MOTS-c Levels in Hashimoto’s Thyroiditis Reflect Integrated Autoimmune and Metabolic Dysregulation: A Cross-Sectional Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15114002 PMID 42278864 Open-access full textSource: ORCID

  3. Relationship Between the Degree of Diabetic Retinopathy and Serum Fractalkine (CX3CL1) in Patients with Type 2 Diabetes: A Single-Center Cross-Sectional Study

    Medicina, 2026

    DOI 10.3390/medicina62020312 PMID 41752711 Open-access full textSource: ORCID

  4. Association of serum Wnt1-inducible signaling pathway protein 1 (WISP1) levels with osteoarthritis and obesity-related inflammation in obese adults

    Scientific reports, 2026

    DOI 10.1038/s41598-026-52502-x PMID 42103993 Open-access full textSource: Europe PMC

  5. 2718-LB: Lower Serum Neuroglobin Levels Are Associated with Distal Symmetric Polyneuropathy in Type 2 Diabetes: A Cross-Sectional Study

    Diabetes, 2026

    DOI 10.2337/db26-2718-lb Source: OpenAlex

  6. The Clinical Significance of Serum Sirtuin 2 in Diabetic Nephropathy: Evidence for a Potential Biomarker of Renal Injury

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14228095 PMID 41303131 2 citations (Europe PMC) Open-access full textSource: ORCID

  7. Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Erectile Dysfunction in Diabetic Patients

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14124029 PMID 40565774 Open-access full textSource: ORCID

  8. The Relationship of the Plasma Glycated CD59 Level with Microvascular Complications in Diabetic Patients and Its Evaluation as a Predictive Marker

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14134588 PMID 40648962 4 citations (Europe PMC) Open-access full textSource: ORCID

  9. VITAMIN D AND VITAMIN D BINDING PROTEIN LEVELS IN COVID-19 INTENSIVE CARE UNIT PATIENTS: A PROSPECTIVE MULTICENTER STUDY

    Journal of Medical Biochemistry, 2024

    DOI 10.5937/jomb0-47822 PMID 39139171 Open-access full textSource: ORCID

  10. Tip 2 Diyabetli Hastalarda Serum Resistin Düzeyleri İle Obezite ve İnsülin Direnci Arasındaki İlişki

    DergiPark (Istanbul University), 2017

    1 citation (OpenAlex) Open-access full textSource: OpenAlex